← Eichor
Study identifier: NCT07323173 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

Condition: Systemic Lupus Erythematosus  ·  Sponsor: Nanjing Leads Biolabs Co.,Ltd

PhasePhase 1
Planned participants112
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

A Phase I, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Study of Single Subcutaneous Injections of LBL-047 in Healthy Adults and Patients with systemic lupus erythematosus.

This description comes directly from the study's public registry record.

Talk to the study team

lei liu  ·  025-83378099  ·  liulei@leadsbiolabs.com

Always discuss trial participation with your own doctor first.

Locations (11)

The First Affiliated Hospital of Bengbu Medical UniversityBengbu, Anhui, ChinaNot Yet Recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaNot Yet Recruiting
Xiangya School of Medicine of Central South UniversityChangsha, Hunan, ChinaNot Yet Recruiting
Nanjing Drum Tower HospitalNanjing, Jiangsu, ChinaNot Yet Recruiting
Pingxiang People's HospitalPingxiang, Jiangxi, ChinaNot Yet Recruiting
Shanghai JiaoTong University School of Medicine,Renji HospitalShanghai, Shanghai Municipality, ChinaNot Yet Recruiting
Shanghai Public Health Clinical CenterShanghai, Shanghai Municipality, ChinaRecruiting
Shanxi Bethune HospitalTaiyuan, Shanxi, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Xian Jiaotong UniversityXian, Shanxi, ChinaNot Yet Recruiting
West China Hospital of Sichuan UniversityChengdu, Sichuan, ChinaNot Yet Recruiting
Mianyang Central HospitalMianyang, Sichuan, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07323173